1. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. 2004; Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 15:2208–2218. DOI:
10.1097/01.ASN.0000133041.27682.A2. PMID:
15284307.
Article
3. Iimori S, Mori Y, Akita W, et al. 2012; Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study. Clin Exp Nephrol. 16:930–937. DOI:
10.1007/s10157-012-0640-4. PMID:
22581064.
Article
4. Chertow GM, Burke SK, Raggi P. Treat to Goal Working Group. 2002; Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 62:245–252. DOI:
10.1046/j.1523-1755.2002.00434.x. PMID:
12081584.
Article
5. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. 2009; KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. (113):S1–S130.
7. Chintamaneni P, Das R, Kuan SF, Kermanshahi TR, Hashash JG. 2014; Hematochezia associated with sevalamer-induced mucosal injury. ACG Case Rep J. 1:145–147. DOI:
10.14309/crj.2014.32. PMID:
26157856. PMCID:
PMC4435309.
Article
8. Magee J, Robles M, Dunaway P. 2018; Sevelamer-induced gastrointestinal injury presenting as gastroenteritis. Case Rep Gastroenterol. 12:41–45. DOI:
10.1159/000486192. PMID:
29515344. PMCID:
PMC5836209.
Article
9. Swanson BJ, Limketkai BN, Liu TC, et al. 2013; Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury. Am J Surg Pathol. 37:1686–1693. DOI:
10.1097/PAS.0b013e3182999d8d. PMID:
24061514.
10. Kim T, de Oliveira Silva Lautenschlager S, Ma Q, et al. 2020; Drug crystal-related gastrointestinal complications involve crystal-induced release of neutrophil and monocyte extracellular traps. Cells. 9:2481. DOI:
10.3390/cells9112481. PMID:
33203124. PMCID:
PMC7697008.
Article
12. Bansal V, Aggarwal P, Mittal A, Vachhani M, Aggarwal P, Aggarwal N. 2017; Colonic mass secondary to sevelamer-associated mucosal injury. ACG Case Rep J. 4:e92. DOI:
10.14309/crj.2017.92. PMID:
28798940. PMCID:
PMC5541759.
Article
14. Kim J, Olson K, Butani L. 2016; Sevelamer crystals in the mucosa of the gastrointestinal tract in a teenager with end-stage renal disease. Pediatr Nephrol. 31:339–341. DOI:
10.1007/s00467-015-3269-1. PMID:
26563116.
Article
15. George SA, Francis I. 2019; Pathology of resin-induced gastrointestinal damage: report of 15 cases and review of literature. Turk Patoloji Derg. 35:221–227. DOI:
10.5146/tjpath.2018.01458. PMID:
31026044.
Article